GALMED PHARMACEUTICALS LTD. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax
GALMED PHARMACEUTICALS LTD. (GLMD) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax of $52.00 thousand for the 3-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2026-06-30 was $52.00K.
- GALMED PHARMACEUTICALS LTD. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2025-06-30 was -$6.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 6 month |
|---|---|---|
| 2026-06-30 | $52.00K 6-K · filed 2026-09-02 | -$28.00K 6-K · filed 2026-09-02 |
| 2025-06-30 | -$6.00K 6-K · filed 2026-09-02 | $13.00K 6-K · filed 2026-09-02 |